A comprehensive assessment of environmental exposures among 1000 North American patients with primary sclerosing cholangitis, with and without inflammatory bowel disease

被引:43
作者
Eaton, J. E. [1 ]
Juran, B. D. [1 ]
Atkinson, E. J. [2 ]
Schlicht, E. M. [1 ]
Xie, X. [2 ]
de Andrade, M. [2 ]
Lammert, C. S. [3 ]
Luketic, V. A. [4 ]
Odin, J. A. [5 ]
Koteish, A. A. [6 ]
Kowdley, K. V. [7 ]
Chopra, K. B. [8 ]
Hirschfield, G. M. [9 ,10 ]
Chalasani, N. P. [3 ]
Lazaridis, K. N. [1 ]
机构
[1] Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA
[2] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN 55905 USA
[3] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA
[4] Virginia Commonwealth Univ, Gastroenterol & Hepatol Sect, Richmond, VA USA
[5] Mt Sinai Sch Med, Dept Med, New York, NY USA
[6] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
[7] Swedish Med Ctr, Liver Care Network, Seattle, WA USA
[8] Univ Pittsburgh, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA USA
[9] Univ Birmingham, Liver Res Ctr, Birmingham, W Midlands, England
[10] Univ Birmingham, NIHR Biomed Res Unit, Birmingham, W Midlands, England
关键词
GLYCATION END-PRODUCTS; RISK-FACTORS; FATTY-ACIDS; DIET; EPIDEMIOLOGY; PATHOGENESIS; POPULATION; MICROBIOME; MANAGEMENT; REDUCTION;
D O I
10.1111/apt.13154
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
BackgroundThe relationships between primary sclerosing cholangitis (PSC) and the environment are largely unknown. AimTo validate associations reported in previous studies and to identify novel environmental exposures among PSC patients. MethodsWe performed a multicenter, case-control analysis utilising self-administered questionnaires. Responses between cases (n=1000) and controls (n=663) were compared using multivariable logistic regression adjusted for age and gender. The model was further stratified based on inflammatory bowel disease (IBD) status (with IBD n=741 without IBD n=259). ResultsSmoking was associated with PSC only when IBD was present (OR, 0.5; 95% CI 0.4-0.7) but not among those PSC patients without IBD (OR, 0.9; 95% CI 0.7-1.2). Compared to controls, women with PSC (irrespective of the presence of IBD) were less likely to have received hormone replacement therapy (HRT; OR, 0.5; 95% CI 0.4-0.7) and were more likely to have recurrent urinary tract infections (OR, 1.6; 95% CI 1.2-2.3). PSC patients regardless of gender or IBD status were less likely to eat fish (OR, 0.4; 95% CI 0.3-0.6) and grilled/barbecued meat (OR, 0.8; 95% CI 0.7-0.9). In contrast, PSC patients with and without IBD were more likely to consume steak/burgers that were more well done (OR, 1.3; 95% CI 1.2-1.5). ConclusionsIBD (rather than PSC) is associated with smoking. Women with PSC are more likely to have recurrent urinary tract infections and less likely to receive HRT. Dietary intake and methods of food preparation differ in PSC patients when compared to controls.
引用
收藏
页码:980 / 990
页数:11
相关论文
共 46 条
[1]
Diet and the Intestinal Microbiome: Associations, Functions, and Implications for Health and Disease [J].
Albenberg, Lindsey G. ;
Wu, Gary D. .
GASTROENTEROLOGY, 2014, 146 (06) :1564-1572
[2]
Effects of Coffee Consumption, Smoking, and Hormones on Risk for Primary Sclerosing Cholangitis [J].
Andersen, Ina Marie ;
Tengesdal, Guro ;
Lie, Benedicte Alexandra ;
Boberg, Kirsten Muri ;
Karlsen, Tom Hemming ;
Hov, Johannes Roksund .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2014, 12 (06) :1019-1028
[3]
Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community [J].
Bambha, K ;
Kim, WR ;
Talwalkar, J ;
Torgerson, H ;
Benson, JT ;
Therneau, TM ;
Loftus, EV ;
Yawn, BP ;
Dickson, ER ;
Melton, LJ .
GASTROENTEROLOGY, 2003, 125 (05) :1364-1369
[4]
Emigration to western industrialized countries: A risk factor for developing inflammatory bowel disease [J].
Barreiro-de Acosta, M. ;
Alvarez Castro, A. ;
Souto, R. ;
Iglesias, M. ;
Lorenzo, A. ;
Dominguez-Munoz, J. E. .
JOURNAL OF CROHNS & COLITIS, 2011, 5 (06) :566-569
[5]
A DATA-BASED APPROACH TO DIET QUESTIONNAIRE DESIGN AND TESTING [J].
BLOCK, G ;
HARTMAN, AM ;
DRESSER, CM ;
CARROLL, MD ;
GANNON, J ;
GARDNER, L .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1986, 124 (03) :453-469
[6]
VALIDATION OF A SELF-ADMINISTERED DIET HISTORY QUESTIONNAIRE USING MULTIPLE DIET RECORDS [J].
BLOCK, G ;
WOODS, M ;
POTOSKY, A ;
CLIFFORD, C .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1990, 43 (12) :1327-1335
[7]
REVISION OF DIETARY ANALYSIS SOFTWARE FOR THE HEALTH HABITS AND HISTORY QUESTIONNAIRE [J].
BLOCK, G ;
COYLE, LM ;
HARTMAN, AM ;
SCOPPA, SM .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1994, 139 (12) :1190-1196
[8]
Bogdanos DP, 2010, DIS MARKERS, V29, P301, DOI [10.1155/2010/595078, 10.3233/DMA-2010-0745]
[9]
Population-Based Epidemiology, Malignancy Risk, and Outcome of Primary Sclerosing Cholangitis [J].
Boonstra, Kirsten ;
Weersma, Rinse K. ;
van Erpecum, Karel J. ;
Rauws, Erik A. ;
Spanier, B. W. Marcel ;
Poen, Alexander C. ;
van Nieuwkerk, Karin M. ;
Drenth, Joost P. ;
Witteman, Ben J. ;
Tuynman, Hans A. ;
Naber, Anton H. ;
Kingma, Paul J. ;
van Buuren, Henk R. ;
van Hoek, Bart ;
Vleggaar, Frank P. ;
van Geloven, Nan ;
Beuers, Ulrich ;
Ponsioen, Cyriel Y. .
HEPATOLOGY, 2013, 58 (06) :2045-2055
[10]
Hepatic expression of galectin-3 and receptor for advanced glycation end products in patients with liver disease [J].
Butscheid, M. ;
Hauptvogel, P. ;
Fritz, P. ;
Klotz, U. ;
Alscher, D. M. .
JOURNAL OF CLINICAL PATHOLOGY, 2007, 60 (04) :415-418